Investing.com — Medical (TASE:) device manufacturer Stryker (NYSE:) is reportedly in the final stages of negotiations to acquire Inari Medical, a company that produces devices for the treatment of venous diseases. The rumor was posted on Monday by Reuters who cited anonumous individuals familiar with the matter.
If the negotiations are successfull, an announcement of the acquisition could be made as early as this week. Inari Medical, which has a market value approaching $3 billion, would enhance Stryker’s portfolio by expanding its treatment options for venous thromboembolism, a condition characterized by blood-vein clotting, and other venous diseases.
In recent weeks, Inari has been considering a sale after receiving acquisition interest from Stryker and other parties. The insiders warned that another potential buyer could still approach Inari, and there is a possibility that no deal may be finalized with any of the interested parties.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Source link
